In Hollywood, a new cosmetic concern dubbed “Ozempic face” is becoming increasingly prevalent, particularly among celebrities using the weight loss drug Semaglutide, commonly known as Ozempic.
This term refers to the facial changes that occur due to rapid and significant weight loss, such as hollowed cheeks, sagging skin, and a generally gaunter appearance. This phenomenon is not just a cosmetic oddity but a reflection of the drug’s side effects on the body’s fat distribution and skin elasticity.
Plastic surgeons have reported a surge in patients seeking treatments to counteract these effects. The American Academy of Facial Plastic and Reconstructive Surgery noted that 60% of their members have seen an increase in patients presenting with symptoms of “Ozempic face.” Common treatments to address these issues include dermal fillers, fat grafting, and in some cases, more invasive procedures like face and neck lifts​.
Ozempic, primarily a medication for type 2 diabetes and weight management, has been widely adopted off-label for its weight loss benefits. The rapid fat reduction it facilitates can lead to significant facial volume loss, accelerating signs of aging. The treatments aim not only to restore facial volume but also to enhance overall skin quality and elasticity that can be compromised following such drastic weight loss.
The phenomenon has sparked a broader discussion about the implications of using medical treatments for aesthetic purposes and the importance of considering long-term effects on appearance and health.
As the use of Ozempic and similar medications increases, so does the demand for specialized cosmetic interventions to manage their side effects. Plastic surgeons emphasize the need for patients to choose qualified professionals for any corrective procedures to ensure safe and effective results.
